Orum Therapeutics, Inc. Periodic Report
AI summary · Not investment advice
Orum Therapeutics sold about KRW 24.9 million in Q3 and lost KRW 16.1 billion from its main business, versus a loss of KRW 13.9 billion a year earlier.
Operating profit · 3 months
KRW -16.1 billion
Key facts
- Revenue (3 months)
- KRW 24.9 million
- Net income (3 months)
- KRW -18.4 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 15.9 million
- Revenue (year to date)
- KRW 49.0 million
- Operating profit (prior-year 3 months)
- KRW -13.9 billion
- Operating profit (year to date)
- KRW -49.5 billion
- Net income (prior-year 3 months)
- KRW -13.6 billion
- Net income (year to date)
- KRW 29.7 billion
Commentary
AI commentary · Not investment advice
What happened
Oreum Therapeutics filed its quarterly report with consolidated results for the third quarter of 2026. Sales for the latest 3 months were KRW 24.9 million, up 56.4% from KRW 15.9 million a year earlier. Cumulative sales this year are KRW 48.96 million.
In the company's terms
Operating profit (profit from the core business) for the latest 3 months was a loss of KRW 16.08 billion. A year earlier, the same 3 months showed a loss of KRW 13.94 billion. Cumulative operating profit this year is a loss of KRW 49.51 billion.
What changes for shareholders
Net income (the final profit after taxes and all other items) for the latest 3 months was a loss of KRW 18.44 billion. A year earlier, the same 3 months showed a loss of KRW 13.62 billion. Cumulative net income this year is positive at KRW 29.66 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
O